[Combination chemotherapy of peplomycin, vincristine, mitomycin C, and cisplatin in gynecologic carcinomas]. 1994

T Tamada, and R Hayase, and A Seki, and J Yamamoto, and J Kodama, and M Yoshinouchi, and Y Kobashi, and H Okuda, and T Kudo
Dept. of Obstetrics and Gynecology, Okayama University Medical School.

UI MeSH Term Description Entries
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002583 Uterine Cervical Neoplasms Tumors or cancer of the UTERINE CERVIX. Cancer of Cervix,Cancer of the Cervix,Cancer of the Uterine Cervix,Cervical Cancer,Cervical Neoplasms,Cervix Cancer,Cervix Neoplasms,Neoplasms, Cervical,Neoplasms, Cervix,Uterine Cervical Cancer,Cancer, Cervical,Cancer, Cervix,Cancer, Uterine Cervical,Cervical Cancer, Uterine,Cervical Cancers,Cervical Neoplasm,Cervical Neoplasm, Uterine,Cervix Neoplasm,Neoplasm, Cervix,Neoplasm, Uterine Cervical,Uterine Cervical Cancers,Uterine Cervical Neoplasm
D002945 Cisplatin An inorganic and water-soluble platinum complex. After undergoing hydrolysis, it reacts with DNA to produce both intra and interstrand crosslinks. These crosslinks appear to impair replication and transcription of DNA. The cytotoxicity of cisplatin correlates with cellular arrest in the G2 phase of the cell cycle. Platinum Diamminodichloride,cis-Diamminedichloroplatinum(II),cis-Dichlorodiammineplatinum(II),Biocisplatinum,Dichlorodiammineplatinum,NSC-119875,Platidiam,Platino,Platinol,cis-Diamminedichloroplatinum,cis-Platinum,Diamminodichloride, Platinum,cis Diamminedichloroplatinum,cis Platinum
D005260 Female Females
D005833 Genital Neoplasms, Female Tumor or cancer of the female reproductive tract (GENITALIA, FEMALE). Gynecologic Neoplasms,Female Genital Neoplasms,Neoplasms, Female Genital,Neoplasms, Gynecologic,Female Genital Neoplasm,Genital Neoplasm, Female,Gynecologic Neoplasm,Neoplasm, Female Genital,Neoplasm, Gynecologic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000971 Antineoplastic Combined Chemotherapy Protocols The use of two or more chemicals simultaneously or sequentially in the drug therapy of neoplasms. The drugs need not be in the same dosage form. Anticancer Drug Combinations,Antineoplastic Agents, Combined,Antineoplastic Chemotherapy Protocols,Antineoplastic Drug Combinations,Cancer Chemotherapy Protocols,Chemotherapy Protocols, Antineoplastic,Drug Combinations, Antineoplastic,Antineoplastic Combined Chemotherapy Regimens,Combined Antineoplastic Agents,Agent, Combined Antineoplastic,Agents, Combined Antineoplastic,Anticancer Drug Combination,Antineoplastic Agent, Combined,Antineoplastic Chemotherapy Protocol,Antineoplastic Drug Combination,Cancer Chemotherapy Protocol,Chemotherapy Protocol, Antineoplastic,Chemotherapy Protocol, Cancer,Chemotherapy Protocols, Cancer,Combinations, Antineoplastic Drug,Combined Antineoplastic Agent,Drug Combination, Anticancer,Drug Combination, Antineoplastic,Drug Combinations, Anticancer,Protocol, Antineoplastic Chemotherapy,Protocol, Cancer Chemotherapy,Protocols, Antineoplastic Chemotherapy,Protocols, Cancer Chemotherapy
D014750 Vincristine An antitumor alkaloid isolated from VINCA ROSEA. (Merck, 11th ed.) Leurocristine,Citomid,Farmistin,Oncovin,Oncovine,Onkocristin,Vincasar,Vincasar PFS,Vincristin Bristol,Vincristin medac,Vincristine Sulfate,Vincrisul,Vintec,cellcristin,PFS, Vincasar,Sulfate, Vincristine

Related Publications

T Tamada, and R Hayase, and A Seki, and J Yamamoto, and J Kodama, and M Yoshinouchi, and Y Kobashi, and H Okuda, and T Kudo
December 1984, Gan to kagaku ryoho. Cancer & chemotherapy,
T Tamada, and R Hayase, and A Seki, and J Yamamoto, and J Kodama, and M Yoshinouchi, and Y Kobashi, and H Okuda, and T Kudo
September 1985, Gan no rinsho. Japan journal of cancer clinics,
T Tamada, and R Hayase, and A Seki, and J Yamamoto, and J Kodama, and M Yoshinouchi, and Y Kobashi, and H Okuda, and T Kudo
August 1989, Gynecologic oncology,
T Tamada, and R Hayase, and A Seki, and J Yamamoto, and J Kodama, and M Yoshinouchi, and Y Kobashi, and H Okuda, and T Kudo
March 1985, Gan to kagaku ryoho. Cancer & chemotherapy,
T Tamada, and R Hayase, and A Seki, and J Yamamoto, and J Kodama, and M Yoshinouchi, and Y Kobashi, and H Okuda, and T Kudo
March 1986, Gan to kagaku ryoho. Cancer & chemotherapy,
T Tamada, and R Hayase, and A Seki, and J Yamamoto, and J Kodama, and M Yoshinouchi, and Y Kobashi, and H Okuda, and T Kudo
January 1995, Gan to kagaku ryoho. Cancer & chemotherapy,
T Tamada, and R Hayase, and A Seki, and J Yamamoto, and J Kodama, and M Yoshinouchi, and Y Kobashi, and H Okuda, and T Kudo
August 1990, Nihon Gan Chiryo Gakkai shi,
T Tamada, and R Hayase, and A Seki, and J Yamamoto, and J Kodama, and M Yoshinouchi, and Y Kobashi, and H Okuda, and T Kudo
March 1985, Gynecologic oncology,
T Tamada, and R Hayase, and A Seki, and J Yamamoto, and J Kodama, and M Yoshinouchi, and Y Kobashi, and H Okuda, and T Kudo
February 1987, Gynecologic oncology,
T Tamada, and R Hayase, and A Seki, and J Yamamoto, and J Kodama, and M Yoshinouchi, and Y Kobashi, and H Okuda, and T Kudo
November 1991, Nihon Sanka Fujinka Gakkai zasshi,
Copied contents to your clipboard!